Products 391210-10-9
CAS 391210-10-9 appears in our catalog under these names: PD 0325901, Mirdametinib, 98%, PD0325901, Mirdametinib/ 99.91% (existing batch purity), PD 0325901, >97.0%(HPLC)(T). Offered by: Chemat Brand, AmBeed, GLPBio, TargetMol, Biosynth. Available pack sizes: on request, 25mg, 10mg, 100mg, 5mg, 10mM (in 1ml dmso), 500mg, 1g.
PD 0325901 is a hydroxamic acid ester that is benzhydroxamic acid (N-hydroxybenzamide) in which the hydroxamic acid group has been converted to the corresponding 2,3-dihydroxypropyl ester and in which the benzene ring has been substituted at position 2 by a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 by fluorines (the R enantiomer). It has a role as an antineoplastic agent and an EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor. It is a member of propane-1,2-diols, an organoiodine compound, a difluorobenzene, a secondary amino compound, a hydroxamic acid ester and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C16H14F3IN2O4 |
|---|---|
| Molecular weight | 482.19 g/mol |
| IUPAC name | N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide |
| InChIKey | SUDAHWBOROXANE-SECBINFHSA-N |
| SMILES | C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O |
Computed by PubChem (NCBI)